Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. reported earnings results for the half year ended June 30, 2024. For the half year, the company reported sales was CNY 531.75 million compared to CNY 412.76 million a year ago. Net income was CNY 114.14 million compared to CNY 91.1 million a year ago.

Basic earnings per share from continuing operations was CNY 0.35 compared to CNY 0.2846 a year ago.